Contact
searchSearch
HMP Global

Crohn's Disease Topic Center

Featured Content

News
FDA Expands Approval of Mirikizumab to Crohn's Disease 
01/16/2025
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved...
01/16/2025
Advances in Inflammatory Bowel Disease Network
Marla Dubinsky
Conference coverage
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
01/16/2025
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024...
01/16/2025
Advances in Inflammatory Bowel Disease Network
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
Perianal Fistulas as a First Sign of Crohn’s Disease
12/12/2024
The findings of a new study indicate that nearly 10% of patients present with a perianal fistula before their diagnosis with Crohn's disease, with an average diagnostic delay of nearly 4 years.
The findings of a new study indicate that nearly 10% of patients present with a perianal fistula before their diagnosis with Crohn's disease, with an average diagnostic delay of nearly 4 years.
The findings of a new study...
12/12/2024
Advances in Inflammatory Bowel Disease Network
Anthony de Buck
Conference coverage
Anthony de Buck, MD, on Positioning Surgery for Crohn's Disease
12/10/2024
Dr de Buck explains how early surgery may be an excellent option in Crohn's disease, when to provide adjuvant medical therapy, monitoring patients after procedures, and that the type of surgery is less important than the timing.
Dr de Buck explains how early surgery may be an excellent option in Crohn's disease, when to provide adjuvant medical therapy, monitoring patients after procedures, and that the type of surgery is less important than the timing.
Dr de Buck explains how early...
12/10/2024
Advances in Inflammatory Bowel Disease Network
Video
James Lewis, MD, on Diet and Nutrition in Crohn's Disease
12/09/2024
Dr James Lewis, from the University of Pennsylvania, recaps his presentation on using diet as an adjunct to medical therapy for Crohn's disease, and its potential to induce remission and even prevent IBD among those at high risk.
Dr James Lewis, from the University of Pennsylvania, recaps his presentation on using diet as an adjunct to medical therapy for Crohn's disease, and its potential to induce remission and even prevent IBD among those at high risk.
Dr James Lewis, from the...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Conference coverage
Case Study Sheds Light on Rare and Challenging Presentation of Crohn’s Disease
12/09/2024
A rare presentation of Crohn’s disease with life-threatening bleeding posed significant diagnostic and treatment hurdles—until a novel therapy achieved remission.
A rare presentation of Crohn’s disease with life-threatening bleeding posed significant diagnostic and treatment hurdles—until a novel therapy achieved remission.
A rare presentation of Crohn’s...
12/09/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Symptom Relief in Crohn’s Disease
12/06/2024
Significant improvements in stool frequency and abdominal pain where seen within the first week of treatment with upadacitinib.
Significant improvements in stool frequency and abdominal pain where seen within the first week of treatment with upadacitinib.
Significant improvements in...
12/06/2024
Advances in Inflammatory Bowel Disease Network
News
MRI and Blood Biomarkers Predict Surgery Risk in Ileal Crohn’s Disease
12/05/2024
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
Video
Remo Panaccione, MD, on the GRAVITI Trials of Guselkumab in Crohn's Disease
12/02/2024
Dr Panaccione reviews the latest trial results for guselkumab in treating Crohn's disease, showing that both IV and subcutaneous induction are superior to placebo.
Dr Panaccione reviews the latest trial results for guselkumab in treating Crohn's disease, showing that both IV and subcutaneous induction are superior to placebo.
Dr Panaccione reviews the latest...
12/02/2024
Advances in Inflammatory Bowel Disease Network

News

News
FDA Expands Approval of Mirikizumab to Crohn's Disease 
01/16/2025
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved...
01/16/2025
Advances in Inflammatory Bowel Disease Network
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
MRI and Blood Biomarkers Predict Surgery Risk in Ileal Crohn’s Disease
12/05/2024
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
What Drives Medication Adherence—or Nonadherence—in Crohn’s Disease?
11/22/2024
A fuller understanding of the cognitive and behavioral factors that guide patients in using medications for Crohn’s disease is essential to developing effective interventions to improve adherence to treatment.
A fuller understanding of the cognitive and behavioral factors that guide patients in using medications for Crohn’s disease is essential to developing effective interventions to improve adherence to treatment.
A fuller understanding of the...
11/22/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/18/2024
The modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The modified Clermont score was...
11/18/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
FDA Expands Approval of Mirikizumab to Crohn's Disease 
01/16/2025
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved...
01/16/2025
Advances in Inflammatory Bowel Disease Network
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Effective for Crohn’s Disease Regardless of Prior Biologic Failure
12/06/2024
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor...
12/06/2024
Advances in Inflammatory Bowel Disease Network
News
MRI and Blood Biomarkers Predict Surgery Risk in Ileal Crohn’s Disease
12/05/2024
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extraintestinal Risks in IBD: Who’s Most Vulnerable?
12/05/2024
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
AI Breakthrough in Crohn’s Disease: Automated Imaging Enhances Diagnosis
12/04/2024
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model...
12/04/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network

Interactive Features

medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
doc writing notes
Quiz
SIBO and Crohn's Disease
04/28/2023
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small...
04/28/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
Does Crohn's Disease or Ulcerative Colitis Present the Highest Risk of Multiple EIMs?
12/11/2023
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations...
12/11/2023
Advances in Inflammatory Bowel Disease Network
light bulb+quiz
Quiz
Positioning Diet for Crohn's Disease
09/04/2023
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some...
09/04/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
The 3 Pillars of IBD Care
07/18/2023
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential...
07/18/2023
Advances in Inflammatory Bowel Disease Network
medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
Quiz
Role of Biologic Agents in IBD
06/14/2023
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate...
06/14/2023
Advances in Inflammatory Bowel Disease Network
coffee+quiz
Quiz
Resection or Medical Therapy for Early Ileocecal Crohn Disease?
05/24/2023
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility...
05/24/2023
Advances in Inflammatory Bowel Disease Network
doc writing notes
Quiz
SIBO and Crohn's Disease
04/28/2023
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small...
04/28/2023
Advances in Inflammatory Bowel Disease Network
Clostridioides difficile
Quiz
Increased Risk of Clostridioides difficile Among Patients with IBD
04/01/2023
In her presentation at the virtual Advances in Inflammatory Bowel Disease meeting on April 30, Monika Fischer, MD, stated, “Individuals with IBD [inflammatory bowel disease] are at 5-fold risk of getting CDI [Clostridioides difficile], more...
In her presentation at the virtual Advances in Inflammatory Bowel Disease meeting on April 30, Monika Fischer, MD, stated, “Individuals with IBD [inflammatory bowel disease] are at 5-fold risk of getting CDI [Clostridioides difficile], more...
In her presentation at the...
04/01/2023
Advances in Inflammatory Bowel Disease Network
OR shot
Quiz
Colectomy Rates Among Patients With UC
02/22/2023
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates...
02/22/2023
Advances in Inflammatory Bowel Disease Network
colonoscopy
Quiz
Endoscopic Healing in Crohn Disease
07/04/2022
A recent study compared the rates of endoscopic healing after 1 year of therapy with different classes of medications. Do you know which won out? Take our quiz to find out!
A recent study compared the rates of endoscopic healing after 1 year of therapy with different classes of medications. Do you know which won out? Take our quiz to find out!
A recent study compared the...
07/04/2022
Advances in Inflammatory Bowel Disease Network

Insights

Marla Dubinsky
Conference coverage
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
01/16/2025
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024...
01/16/2025
Advances in Inflammatory Bowel Disease Network
Anthony de Buck
Conference coverage
Anthony de Buck, MD, on Positioning Surgery for Crohn's Disease
12/10/2024
Dr de Buck explains how early surgery may be an excellent option in Crohn's disease, when to provide adjuvant medical therapy, monitoring patients after procedures, and that the type of surgery is less important than the timing.
Dr de Buck explains how early surgery may be an excellent option in Crohn's disease, when to provide adjuvant medical therapy, monitoring patients after procedures, and that the type of surgery is less important than the timing.
Dr de Buck explains how early...
12/10/2024
Advances in Inflammatory Bowel Disease Network
Video
James Lewis, MD, on Diet and Nutrition in Crohn's Disease
12/09/2024
Dr James Lewis, from the University of Pennsylvania, recaps his presentation on using diet as an adjunct to medical therapy for Crohn's disease, and its potential to induce remission and even prevent IBD among those at high risk.
Dr James Lewis, from the University of Pennsylvania, recaps his presentation on using diet as an adjunct to medical therapy for Crohn's disease, and its potential to induce remission and even prevent IBD among those at high risk.
Dr James Lewis, from the...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Video
Remo Panaccione, MD, on the GRAVITI Trials of Guselkumab in Crohn's Disease
12/02/2024
Dr Panaccione reviews the latest trial results for guselkumab in treating Crohn's disease, showing that both IV and subcutaneous induction are superior to placebo.
Dr Panaccione reviews the latest trial results for guselkumab in treating Crohn's disease, showing that both IV and subcutaneous induction are superior to placebo.
Dr Panaccione reviews the latest...
12/02/2024
Advances in Inflammatory Bowel Disease Network
Phillip Gu
Video
Phillip Gu, MD, on Preventing Postoperative Crohn's Disease Recurrence
09/11/2024
Dr Gu reviews his address at the AIBD regional meeting on the recurrence of postoperative Crohn's disease, including how to assess risks and steps that can help to prevent it.
Dr Gu reviews his address at the AIBD regional meeting on the recurrence of postoperative Crohn's disease, including how to assess risks and steps that can help to prevent it.
Dr Gu reviews his address at the...
09/11/2024
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Video
Florian Rieder, MD, on Optimizing Outcomes in Crohn's Disease
08/21/2024
Dr Rieder reviews the options for treatment of Crohn's disease in terms of safety, treatment of comorbidities, and efficacy for moderate to severe disease.
Dr Rieder reviews the options for treatment of Crohn's disease in terms of safety, treatment of comorbidities, and efficacy for moderate to severe disease.
Dr Rieder reviews the options...
08/21/2024
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Video
Edward Loftus, MD, on Upadacitinib in Crohn's Disease
06/06/2024
Dr Loftus recaps his poster presentation on a subanalysis from the upadacitinib phase 3 trials in Crohn's disease examining the effect on anxiety, depression, fatigue, and bowel urgency.
Dr Loftus recaps his poster presentation on a subanalysis from the upadacitinib phase 3 trials in Crohn's disease examining the effect on anxiety, depression, fatigue, and bowel urgency.
Dr Loftus recaps his poster...
06/06/2024
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on Postoperative Crohn's Disease
05/15/2024
Dr Regueiro recaps his keynote address on the management postoperative Crohn's disease, including new surgical techniques and medications that could help prevent the occurrence of postoperative disease.
Dr Regueiro recaps his keynote address on the management postoperative Crohn's disease, including new surgical techniques and medications that could help prevent the occurrence of postoperative disease.
Dr Regueiro recaps his keynote...
05/15/2024
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Videos
Florian Rieder, MD, on Positioning Drugs in Crohn's Disease
04/26/2024
Dr Florian Rieder from Cleveland Clinic spoke at the AIBD Regional Meeting on how he approaches positioning different therapies among patients with Crohn's disease.
Dr Florian Rieder from Cleveland Clinic spoke at the AIBD Regional Meeting on how he approaches positioning different therapies among patients with Crohn's disease.
Dr Florian Rieder from Cleveland...
04/26/2024
Advances in Inflammatory Bowel Disease Network
Jordan Axelrad
Video
Jordan Axelrad, MD, on Postoperative Crohn's Disease
04/26/2024
Dr Jordan Axelrad reviews the key points of his presentation on postoperative management for patients with Crohn's disease from the AIBD Regional meeting in Chapel Hill, North Carolina.
Dr Jordan Axelrad reviews the key points of his presentation on postoperative management for patients with Crohn's disease from the AIBD Regional meeting in Chapel Hill, North Carolina.
Dr Jordan Axelrad reviews the...
04/26/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Lin Chang, MD, on IBS in IBD
01/27/2025
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond...
01/27/2025
Advances in Inflammatory Bowel Disease Network
Marla Dubinsky
Conference coverage
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
01/16/2025
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024...
01/16/2025
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Video
Edward Loftus, MD, on Upper GI Crohn's Disease
01/07/2025
Dr Loftus explains how Crohn's disease can affect the upper gastrointestinal system, from the mouth to the duodenum, and the options for treating this rare presentation.
Dr Loftus explains how Crohn's disease can affect the upper gastrointestinal system, from the mouth to the duodenum, and the options for treating this rare presentation.
Dr Loftus explains how Crohn's...
01/07/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD: The Sherman Prize 2024
12/25/2024
Dr Long, one of the winners of the 2024 Sherman Prize, discusses the importance of the prize in helping to move the field of IBD research and treatment forward.
Dr Long, one of the winners of the 2024 Sherman Prize, discusses the importance of the prize in helping to move the field of IBD research and treatment forward.
Dr Long, one of the winners of...
12/25/2024
Advances in Inflammatory Bowel Disease Network
Dermot McGovern
Video
Dermot McGovern, MD: Sherman Prize 2024
12/25/2024
Dr McGovern, one of the winners of the 2024 Sherman Prize, reviews the work of his group at Cedars-Sinai in the genetics of IBD and their efforts to clarify the heterogeneity of ulcerative colitis and Crohn's disease.
Dr McGovern, one of the winners of the 2024 Sherman Prize, reviews the work of his group at Cedars-Sinai in the genetics of IBD and their efforts to clarify the heterogeneity of ulcerative colitis and Crohn's disease.
Dr McGovern, one of the winners...
12/25/2024
Advances in Inflammatory Bowel Disease Network
Jordan Axelrad
Video
Jordan Axelrad, MD: The Sherman Emerging Leader Prize 2024
12/25/2024
Dr Axelrad has become a leader in the area of malignancy among patients with IBD, which was recognized with the Sherman Emerging Leader Prize.
Dr Axelrad has become a leader in the area of malignancy among patients with IBD, which was recognized with the Sherman Emerging Leader Prize.
Dr Axelrad has become a leader...
12/25/2024
Advances in Inflammatory Bowel Disease Network
Anthony de Buck
Conference coverage
Anthony de Buck, MD, on Positioning Surgery for Crohn's Disease
12/10/2024
Dr de Buck explains how early surgery may be an excellent option in Crohn's disease, when to provide adjuvant medical therapy, monitoring patients after procedures, and that the type of surgery is less important than the timing.
Dr de Buck explains how early surgery may be an excellent option in Crohn's disease, when to provide adjuvant medical therapy, monitoring patients after procedures, and that the type of surgery is less important than the timing.
Dr de Buck explains how early...
12/10/2024
Advances in Inflammatory Bowel Disease Network
Video
James Lewis, MD, on Diet and Nutrition in Crohn's Disease
12/09/2024
Dr James Lewis, from the University of Pennsylvania, recaps his presentation on using diet as an adjunct to medical therapy for Crohn's disease, and its potential to induce remission and even prevent IBD among those at high risk.
Dr James Lewis, from the University of Pennsylvania, recaps his presentation on using diet as an adjunct to medical therapy for Crohn's disease, and its potential to induce remission and even prevent IBD among those at high risk.
Dr James Lewis, from the...
12/09/2024
Advances in Inflammatory Bowel Disease Network

Latest News

News
FDA Expands Approval of Mirikizumab to Crohn's Disease 
01/16/2025
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved...
01/16/2025
Advances in Inflammatory Bowel Disease Network
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
MRI and Blood Biomarkers Predict Surgery Risk in Ileal Crohn’s Disease
12/05/2024
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
What Drives Medication Adherence—or Nonadherence—in Crohn’s Disease?
11/22/2024
A fuller understanding of the cognitive and behavioral factors that guide patients in using medications for Crohn’s disease is essential to developing effective interventions to improve adherence to treatment.
A fuller understanding of the cognitive and behavioral factors that guide patients in using medications for Crohn’s disease is essential to developing effective interventions to improve adherence to treatment.
A fuller understanding of the...
11/22/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/18/2024
The modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The modified Clermont score was...
11/18/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
FDA Expands Approval of Mirikizumab to Crohn's Disease 
01/16/2025
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved...
01/16/2025
Advances in Inflammatory Bowel Disease Network
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Effective for Crohn’s Disease Regardless of Prior Biologic Failure
12/06/2024
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor...
12/06/2024
Advances in Inflammatory Bowel Disease Network
News
MRI and Blood Biomarkers Predict Surgery Risk in Ileal Crohn’s Disease
12/05/2024
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extraintestinal Risks in IBD: Who’s Most Vulnerable?
12/05/2024
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
AI Breakthrough in Crohn’s Disease: Automated Imaging Enhances Diagnosis
12/04/2024
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model...
12/04/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

IBD Drive time logo
Podcast
IBD Drive Time: Lin Chang, MD, on IBS in IBD
01/27/2025
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond...
01/27/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use